Bristol-Myers wins FDA nod for novel antipsychotic episode artwork

EPISODE · Sep 27, 2024 · 5 MIN

Bristol-Myers wins FDA nod for novel antipsychotic

from Wall Street Breakfast · host Seeking Alpha

Bristol-Myers (BMY) wins FDA nod for first-of-its-kind antipsychotic. (00:25) DirecTV, Dish (SATS) close in on merger to form largest US pay-TV service: Bloomberg. (01:11) Major Trump Media (DJT) shareholder dumps nearly entire stake. (02:18)Episode transcripts seekingalpha.com/wsb.Show links: Hurricane Helene misses 'most prolific' Gulf of Mexico oil and gas producing areasU.S. and Intel could close $8.5B chip funding by year-end - reportIntel said to rebuff approach by Arm Holdings for product unitSign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.

Episode metadata supplied by the publisher feed · Published Sep 27, 2024

Embed this episode

NOW PLAYING

Bristol-Myers wins FDA nod for novel antipsychotic

0:00 5:02

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Wall Street Breakfast?

This episode is 5 minutes long.

When was this Wall Street Breakfast episode published?

This episode was published on September 27, 2024.

Can I download this Wall Street Breakfast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!